Revive Therapeutics Ltd. (RVV.CN)
Seite 8 von 8 Neuester Beitrag: 25.04.21 00:01 | ||||
Eröffnet am: | 30.03.20 10:25 | von: Chalifmann3 | Anzahl Beiträge: | 179 |
Neuester Beitrag: | 25.04.21 00:01 | von: Kristinujjua | Leser gesamt: | 48.841 |
Forum: | Hot-Stocks | Leser heute: | 21 | |
Bewertet mit: | ||||
Seite: < 1 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | > |
https://www.tradingview.com/symbols/OTC-RVVTF/
https://www.reddit.com/r/RVVTF/comments/lhra14/...bucillamines_phase/
TORONTO, March 19, 2021 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce positive results of a pre-clinical study evaluating the efficacy of psilocybin in the treatment of mild traumatic brain injury (“TBI”) in a rodent model of TBI. The study was conducted at the National Health Research Institutes (“NHRI”), which was part of the psilocybin program acquired from PharmaTher Inc., a subsidiary of Newscope Capital Corporation (CSE: PHRM, OTCQB: PHRRF)...